Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
52%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
PBPH
56
HOLDINGS
24%
ALSO IN MEDX
MEDX
27
HOLDINGS
44%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.5% | 19.1% | 15.5% |
|
ABBVIE INC | 7.2% | 10.3% | 7.2% |
|
JOHNSON & JOHNSON | 10.0% | 6.1% | 6.1% |
|
MERCK & CO. INC. | 5.7% | 4.7% | 4.7% |
 |
ASTRAZENECA PLC | 4.7% | 4.5% | 4.5% |
PBPH Overweight Relative to MEDX
 |
NOVARTIS AG | 4.2% |
|
GILEAD SCIENCES INC | 4.0% |
|
JOHNSON & JOHNSON | 3.9% |
|
VERTEX PHARMACEUTICALS INC | 2.8% |
 |
NOVO NORDISK A/S-B | 2.6% |
|
GSK PLC | 2.0% |
 |
SANOFI-AVENTIS | 1.9% |
|
MODERNA, INC. | 1.5% |
 |
CSL LIMITED | 1.3% |
 |
ARGEN-X SE | 1.3% |
PBPH Underweight Relative to MEDX
|
NOVARTIS AG-ADR | -6.7% |
 |
ALKERMES PLC | -4.5% |
|
ELI LILLY & CO | -3.7% |
|
ABBVIE INC | -3.1% |
|
IONIS PHARMACEUTICALS, INC. | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.7% |
|
BIOGEN IDEC INC | -2.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.5% |
|
ALNYLAM PHARMACEUTICALS INC | -2.1% |
|
BRISTOL-MYERS SQUIBB CO | -1.6% |